Lenton E A, de Kretser D M, Woodward A J, Robertson D M
University Department of Obstetrics and Gynecology, Jessop Hospital for Women, Sheffield, England.
J Clin Endocrinol Metab. 1991 Dec;73(6):1180-90. doi: 10.1210/jcem-73-6-1180.
Plasma immunoreactive inhibin levels have been measured in a series of normal conception cycles (group I; n = 7), and the data compared to inhibin concentrations in normal menstrual cycles (group II; n = 8), in women with luteal phase defects (group III; n = 7), and in women in the perimenopausal period (group IV; n = 6). Daily plasma levels of LH, FSH, progesterone, estradiol, and inhibin were determined in each subject, and daily mean profiles for each hormone in each subject group were calculated and expressed as geometric means with 68% confidence limits. During the follicular and early luteal phases, inhibin concentrations in the normal nonpregnant group (group II) were significantly higher than those in the conception cycles of group I, but after implantation in the conception cycles, inhibin concentrations increased to levels in excess of those seen at any time in nonconception cycles (716-1352 U/L; P less than 0.02). The postimplantation rise in inhibin did not initially appear to follow the same pattern as progesterone. While progesterone concentrations rose within 24 h of the first detectable increase in hCG, inhibin levels did not increase until 3 days later, although after this point concentrations increased serially and in parallel with progesterone. LH and FSH concentrations were markedly suppressed after implantation. Follicular and early luteal inhibin concentrations in cycles with luteal phase defects were also higher than those in conception cycles, although this difference was only significant in the midfollicular phase. Follicular phase inhibin concentrations in cycles from older women (group IV) were lower than those in groups II and III, but were not distinguishable from those in the conception cycles. Estradiol concentrations in the same subjects were significantly lower during the early follicular phase, while follicular and luteal FSH concentrations were significantly higher than those during conception cycles. Finally, examination of the relationship between inhibin, FSH, and estradiol around menstruation in the older women revealed a far closer temporal association between FSH and estradiol than between FSH and inhibin. In conclusion, inhibin concentrations rise and fall throughout the human menstrual cycle in a manner that is similar to but at specific times significantly different from that of either of the ovarian steroids estradiol and progesterone. It is considered to be a peptide of granulosa cell origin and may be an indicator of the size of the follicular pool during the early stage of the cycle. However, although there is some degree of inverse correlation between profiles of inhibin and profiles of FSH, this relationship is not particularly clear.(ABSTRACT TRUNCATED AT 400 WORDS)
在一系列正常受孕周期(第一组;n = 7)中测量了血浆免疫反应性抑制素水平,并将数据与正常月经周期(第二组;n = 8)、黄体期缺陷女性(第三组;n = 7)以及围绝经期女性(第四组;n = 6)的抑制素浓度进行了比较。测定了每组受试者的促黄体生成素(LH)、促卵泡生成素(FSH)、孕酮、雌二醇和抑制素的每日血浆水平,并计算了每组受试者每种激素的每日平均曲线,以几何平均数表示,并给出68%的置信区间。在卵泡期和黄体早期,正常未孕组(第二组)的抑制素浓度显著高于第一组的受孕周期,但在受孕周期着床后,抑制素浓度升高至非受孕周期任何时候所见水平之上(716 - 1352 U/L;P < 0.02)。着床后抑制素的升高最初似乎与孕酮的模式不同。虽然孕酮浓度在人绒毛膜促性腺激素(hCG)首次可检测到升高后的24小时内升高,但抑制素水平直到3天后才升高,不过在此之后浓度连续升高并与孕酮平行。着床后LH和FSH浓度明显受到抑制。黄体期缺陷周期的卵泡期和黄体早期抑制素浓度也高于受孕周期,尽管这种差异仅在卵泡中期显著。老年女性(第四组)周期的卵泡期抑制素浓度低于第二组和第三组,但与受孕周期的浓度无明显差异。同一受试者在卵泡早期的雌二醇浓度显著较低,而卵泡期和黄体期的FSH浓度显著高于受孕周期。最后,对老年女性月经前后抑制素、FSH和雌二醇之间关系的检查显示,FSH与雌二醇之间的时间关联远比FSH与抑制素之间的紧密。总之,抑制素浓度在人类月经周期中呈上升和下降趋势,其方式与卵巢甾体激素雌二醇和孕酮相似,但在特定时间有显著差异。它被认为是颗粒细胞来源的一种肽,可能是周期早期卵泡池大小的一个指标。然而,尽管抑制素曲线与FSH曲线之间存在一定程度的负相关,但这种关系并不特别明显。(摘要截取自400字)